semaglutide skin Now, Sagging Later: How Spas Are Taking Up the Slack Semaglutide may help manage difficult-to-treat

On December 22, 2025, the FDA approved oral Wegovy (semaglutide 25mg tablet) the first and only oral GLP-1 medication for chronic weight management

When made in compounding pharmacies that use less rigorous stability testing or rely on external data to determine stability, the BUD will be shorter, generally 1428 days , to make sure it stays safe and effective

Fatigue or weakness may be experienced by some patients, particularly during the initial weeks of therapy, and may be related to reduced caloric intake or metabolic adaptation

The highest approved dose is 2 mg weekly , designed for those who need stronger blood sugar management and can tolerate the higher dose

Semaglutide is a GLP-1 analogue used in medications like Wegovy for the treatment of obesity